The authors collected resource utilization and cost of treatment data (in US dollars, excluding physicians' fees) from the cost accounting systems of two Canadian hospitals (n=215) and seven US ...

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction ...

Patients without standard modifiable cardiovascular risk factors (SMuRFs) who present with acute MI are at an increased risk of dying when compared with those who present with at least one risk factor ...

Early use of sodium-glucose cotransporter 2 (SGLT2) inhibitors may improve outcomes among patients with type 2 diabetes undergoing PCI for an acute MI, a retrospective study indicates. Those started ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. During the first year of the COVID-19 pandemic, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ATLANTA -- The ...

Use of beta-blockers has been a cornerstone in the treatment era following acute myocardial infarction (MI), especially in ...

Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...

Please provide your email address to receive an email when new articles are posted on . Women and diverse populations are underrepresented in popular film depictions of acute MI. Films tend to portray ...

EMPACT-MI is the first analysis to determine if it is safe with respect to the kidney to initiate SGLT2 inhibitors in patients during or soon after hospitalization for acute MI. The researchers ...